https://www.zacks.com/stock/news/2197398/here-s-why-prokidney-corp-prok-is-a-great-buy-the-bottom-stock-now?cid=CS-ZC-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2197398
Dec 13, 2023 - ProKidney Corp. (PROK) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
zc:-987237731852879821
0
https://www.zacks.com/stock/news/2197340/are-investors-undervaluing-fabrinet-fn-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2197340
Dec 13, 2023 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
zc:-3953236551407324937
0
https://www.zacks.com/stock/news/2197341/are-investors-undervaluing-api-group-apg-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2197341
Dec 13, 2023 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
zc:17523846107599147
0
https://www.zacks.com/stock/news/2197348/are-investors-undervaluing-suzano-suz-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2197348
Dec 13, 2023 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
zc:3350554921864689703
0
https://www.fool.com/investing/2023/12/13/2-warren-buffett-growth-stocks-to-buy-now-and-hold/?source=iedfolrf0000001
Dec 13, 2023 - Apple isn't the only red-hot growth stock that's held in the Berkshire Hathaway portfolio.
0
fool:8184817353068777166
0
https://www.zacks.com/stock/news/2197201/is-it-a-good-idea-to-buy-journey-medical-derm-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2197201
Dec 13, 2023 - Here, we discuss some reasons why investing in Journey Medical (DERM) stock now may turn out to be a prudent move.
zc:-6086227823355175591
0
https://www.zacks.com/stock/news/2197202/here-s-why-investors-should-hold-on-to-eqt-stock-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2197202
Dec 13, 2023 - In the prolific Appalachian Basin, EQT has a strong foothold in the natural gas-rich Marcellus and Utica shale plays.
zc:-7887145894353912281
0
https://www.zacks.com/stock/news/2197166/reasons-to-add-atmos-energy-ato-to-your-portfolio-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2197166
Dec 13, 2023 - Atmos Energy (ATO) makes a strong case for investment, given its growth prospects, strong ROE and ability to increase shareholders' value.
zc:5592494620259222747
0
https://www.zacks.com/stock/news/2197165/here-s-why-you-should-retain-mckesson-mck-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2197165
Dec 13, 2023 - McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
zc:1046495554244891306
0
https://www.zacks.com/stock/news/2197157/is-american-funds-smallcap-world-a-smcwx-a-strong-mutual-fund-pick-right-now?cid=CS-ZC-FT-mutual_fund_equity_report-2197157
Dec 13, 2023 - Mutual Fund Report for SMCWX
zc:-2079622669801240748
0